2025f0babb
- raw: raw/xpost/2026-07-18_healthranger-kimi-k3-anthropic-panic.md - wiki: concepts/llm/kimi-k3.md (new concept page) - wiki: institutions/moonshot-ai.md (updated with Kimi K3 section) - wiki: index.md (77. update, new LLM entry + raw source) - wiki: log.md (ingest entry) - fix: broken links in agent-loops.md + graph-based-agents.md Kernaussagen: ~8x cheaper than Claude, open source July 27, safeguard controversy (curcumin/cyclospora block vs. free answer), AI bubble thesis from HealthRanger (Mike Adams).
70 lines
4.3 KiB
Markdown
70 lines
4.3 KiB
Markdown
---
|
||
type: xpost
|
||
source_url: https://x.com/HealthRanger/status/2078329318535491663
|
||
retrieved: 2026-07-18
|
||
author: "@HealthRanger"
|
||
is_thread: true
|
||
quote_count: ~4000
|
||
view_count: 2800000
|
||
tags: [kimi-k3, anthropic, chinese-ai, pricing, open-source, moonshot-ai, ai-bubble, fable-5, claude, cyclospora, curcumin, safety-guardrails]
|
||
people: [mike-adams]
|
||
institutions: [moonshot-ai, anthropic]
|
||
---
|
||
|
||
# HealthRanger: "Anthropic is panicking over the release of Kimi K3"
|
||
|
||
**Source:** [X-Post by @HealthRanger](https://x.com/HealthRanger/status/2078329318535491663)
|
||
**Posted:** 2026-07-18, 4:01 AM UTC
|
||
**Views:** 2.8M | **Quotes:** ~4,000 | **Replies:** 169+
|
||
|
||
## Author Context
|
||
|
||
**HealthRanger** = Mike Adams, founder of NaturalNews.com and Brighteon.com. Known for provocative anti-establishment takes on health, nutrition, and technology. His framing is intentionally alarmist and pro-alternative-medicine / anti-Big-Tech. Claims should be verified against primary sources.
|
||
|
||
## Main Post Content
|
||
|
||
> "Anthropic is panicking over the release of Kimi K3. In fact, the entire U.S. AI frontier lab ecosystem is panicking right now.
|
||
>
|
||
> When investors figure out that U.S. frontier labs have no viable long-term revenue model from paying retail customers (because China's models are both better and cheaper), the AI investment bubble will crash."
|
||
|
||
**Referenced:** Anthropic's announcement that Claude Fable 5 will be included in Max and Team Premium plans starting July 20, at 50% of limits — with Pro/Team Standard users receiving a one-time $100 credit. HealthRanger frames this as panic over Kimi K3 competition.
|
||
|
||
## Comparison Tweet: Kimi K3 vs. Claude Fable 5
|
||
|
||
**Source:** [https://x.com/HealthRanger/status/2078256802630619359](https://x.com/HealthRanger/status/2078256802630619359) (40.6K Views)
|
||
|
||
HealthRanger asked both models to research how turmeric (curcumin) kills the cyclospora parasite (causing explosive diarrhea from contaminated fresh vegetables).
|
||
|
||
**Claude Fable 5:** Blocked the query — "This model has safeguards that flagged something in this session." FAIL.
|
||
|
||
**Kimi K3:** Delivered a detailed, sourced answer:
|
||
- Found the original 2023 peer-reviewed paper (Mogahed, Gaafar, Shalaby, Sheta & Arafa, "Potential efficacy of curcumin and curcumin nanoemulsion against experimental cyclosporiasis," Parasitologists United Journal, 2023;16(3):197–207, DOI: 10.21608/PUJ.2023.237883)
|
||
- Searched for PDFs across mirrors
|
||
- Read and summarized the paper
|
||
- Confirmed findings while noting it was **mice research, not human research** (important caveat)
|
||
- Traced the viral spread: Substack post by Nicolas Hulscher (McCullough Foundation) + NaturalNews article, riding coverage of the current U.S. Cyclospora outbreak
|
||
|
||
**HealthRanger's framing:** "Anthropic, built in the USA, is useless but also extremely expensive when it happens to actually do something. Kimi-K3, created in China, is incredibly useful and also ridiculously low-cost. Plus it doesn't accuse you of building a bioweapon when you just want to find out about which herbs halt explosive diarrhea-causing parasites."
|
||
|
||
## Additional Claims from the Thread
|
||
|
||
- **Kimi K3 Open Source:** Announced for July 27, 2026
|
||
- **US companies migrating:** Cursor, Coinbase, Shopify, Airbnb reportedly shifting workloads to Chinese models
|
||
- **Pricing:** Kimi K3 is ~8× cheaper than Claude equivalents (~$15/M Tokens)
|
||
- **AI Bubble Thesis:** US frontier labs have no viable long-term revenue model because Chinese models are both better and cheaper
|
||
|
||
## Key Takeaways
|
||
|
||
1. **Safeguard asymmetry:** Claude blocks health/nutrition queries that Kimi K3 answers freely — this is both a feature (safety) and a risk (censorship vs. utility tradeoff)
|
||
2. **Cost disruption:** ~8× cheaper pricing makes the US premium model unsustainable if quality parity holds
|
||
3. **Open Source threat:** July 27 open-source release would make Kimi K3 available for self-hosting, bypassing API pricing entirely
|
||
4. **HealthRanger's bias:** Source is inherently polemical; the core claims (pricing, open-source date, safeguard differences) are verifiable, but the "panic" framing is editorial
|
||
|
||
## Cross-References
|
||
|
||
- [[../../wiki/concepts/llm/kimi-k3.md]]
|
||
- [[../../wiki/concepts/llm/chinese-model-cost-routing.md]]
|
||
- [[../../wiki/concepts/llm/ai-investment-bubble.md]]
|
||
- [[../../wiki/concepts/llm/fable-5-anthropic.md]]
|
||
- [[../../wiki/institutions/moonshot-ai.md]]
|
||
- [[../../wiki/institutions/anthropic.md]]
|